Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bartl

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Physiology|November 16, 2018
I<sub>h</sub> contributes to increased motoneuron excitability in restless legs syndromeDirk Czesnik, James Howells, Michael Bartl, et al.
International Journal of Molecular Sciences|December 11, 2025
Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's DiseaseMary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein SeedsSandrina Weber, Carly M Farris, Yihua Ma, et al.
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Angewandte Chemie (International Ed. in English)|August 4, 2025
Expanding the Repertoire of Photoswitchable Unnatural Amino Acids for Enzyme EngineeringCaroline Hiefinger, Michela Marcon, Verena Pape, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2021
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related DisordersIsabel Schulz, Niels Kruse, Roland G Gera, et al.
BMC Neurology|March 22, 2023
Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson's disease on MRISebastian Johannes Müller, Eya Khadhraoui, Niels Hansen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.
NPJ Parkinson'S Disease|May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's diseaseMichael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
Nature Communications|June 18, 2024
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onsetJenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Physiology|November 16, 2018
I<sub>h</sub> contributes to increased motoneuron excitability in restless legs syndromeDirk Czesnik, James Howells, Michael Bartl, et al.
International Journal of Molecular Sciences|December 11, 2025
Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's DiseaseMary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein SeedsSandrina Weber, Carly M Farris, Yihua Ma, et al.
Plos One|October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's diseaseMichael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Angewandte Chemie (International Ed. in English)|August 4, 2025
Expanding the Repertoire of Photoswitchable Unnatural Amino Acids for Enzyme EngineeringCaroline Hiefinger, Michela Marcon, Verena Pape, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 7, 2021
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related DisordersIsabel Schulz, Niels Kruse, Roland G Gera, et al.
BMC Neurology|March 22, 2023
Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson's disease on MRISebastian Johannes Müller, Eya Khadhraoui, Niels Hansen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 21, 2022
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseMichael Bartl, Mohammed Dakna, Sebastian Schade, et al.
NPJ Parkinson'S Disease|May 17, 2024
Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson's diseaseMichael Bartl, Johanna Nilsson, Mohammed Dakna, et al.
Nature Communications|June 18, 2024
Plasma proteomics identify biomarkers predicting Parkinson's disease up to 7 years before symptom onsetJenny Hällqvist, Michael Bartl, Mohammed Dakna, et al.
Pageof 3